沙特阿拉伯王国政府所属的官方政府网站。
沙特官方政府网站的域名以下列后缀结尾 gov.sa
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
政府网站使用以下协议。 HTTPS 用于加密和安全。
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
沙特阿拉伯王国所有政府机构的官方网站均以 .gov.sa 结尾。
| # | العنوان | التاريخ | نوع الخبر | رابط الخبر |
|---|---|---|---|---|
| 83 | Safety Signal of Nivolumab and the Risk of Hypoparathyroidism | Signal | ||
| 82 | Potential Risk of Tumor Lysis Syndrome Associated with the Use Pazopanib | Precautions | ||
| 80 | Safety Signal of Hypokalemia associated with the use of Ceftriaxone | Signal | ||
| 79 | Safety Signal of Molluscum Contagiosum associated with the use of Fingolimod | Signal | ||
| 78 | Safety Signal of Rhabdomyolysis associated with the use of Pembrolizumab | Signal | ||
| 75 | Safety Signal of Skin Cancer associated with the use of Methotrexate | Signal | ||
| 81 | Baricitinib (Olumiant®) and increased risk of diverticulitis: Recommendations for Healthcare Professionals from the SFDA | Precautions | ||
| 76 | Safety Signal of Cardiac Failure associated with the use of Ibrutinib | Signal | ||
| 74 | Switching between Warfarin Brands and The Importance of Close Monitoring of INR | Precautions | ||
| 73 | Hydroxychloroquine and Chloroquine Alone and in Combination with Azithromycin and Potential Increased Risk of Heart Rhythm Problems | Warning |
最后更新日期: 18/06/2026 at 08:23 上午 Saudi Arabia time
此页面尚未收到任何反馈。
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。